Cargando…
Biosynthetic neoantigen displayed on bacteria derived vesicles elicit systemic antitumour immunity
Neoantigens derived from mutant proteins in tumour cells could elicit potent personalized anti‐tumour immunity. Nevertheless, the layout of vaccine vehicle and synthesis of neoantigen are pivotal for stimulating robust response. The power of synthetic biology enables genetic programming bacteria to...
Autores principales: | Meng, Fanqiang, Li, Liyan, Zhang, Zhirang, Lin, Zhongda, Zhang, Jinxie, Song, Xiao, Xue, Tianyuan, Xing, Chenyang, Liang, Xin, Zhang, Xudong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721206/ https://www.ncbi.nlm.nih.gov/pubmed/36468941 http://dx.doi.org/10.1002/jev2.12289 |
Ejemplares similares
-
In situ immunomodulation of tumors with biosynthetic bacteria promote anti-tumor immunity
por: Lin, Zhongda, et al.
Publicado: (2023) -
Genetic engineering cellular vesicles expressing CD64 as checkpoint antibody carrier for cancer immunotherapy
por: Li, Liyan, et al.
Publicado: (2021) -
Neoantigens elicit T cell responses in breast cancer
por: Morisaki, Takafumi, et al.
Publicado: (2021) -
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation
por: Li, Lijin, et al.
Publicado: (2021) -
Modification of PEG reduces the immunogenicity of biosynthetic gas vesicles
por: Wang, Yuanyuan, et al.
Publicado: (2023)